News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

ReVance Therapeutics, Inc. Files $86.25 Million IPO



1/2/2014 7:12:49 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Revance Therapeutics, Inc. (Nasdaq: RVNC) filed a registration with the U.S. Securities and Exchange Commission for an Initial Public Offering of its Common Stock. The proposed maximum offering price is $86.25 million. The company plans to list on the Nasdaq Global Market under the symbol "RVNC."

Help employers find you! Check out all the jobs and post your resume.



comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES